<table-wrap xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="table7" position="float"><label>Table 7.</label><caption><title>Basic characteristics of the study population.</title></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top">Healthy</th><th valign="top">Asthmatics</th></tr></thead><tbody><tr><td valign="top">No history of episodic chest symptoms</td><td valign="top">History of episodic chest symptoms</td></tr><tr><td valign="top">Baseline FEV1&#160;&#8805;&#160;80% predicted</td><td valign="top">Baseline FEV1&#160;&#8805;&#160;70% predicted</td></tr><tr><td valign="top">AHR to methacholine (PC<sub>20</sub>)&#160;&#8805;&#160;19.6 mg/ml</td><td valign="top">AHR to methacholine (PC<sub>20</sub>)&#160;&#8804;&#160;9.8 mg/ml</td></tr><tr><td valign="top">SPT negative for all 12 common <break/>Aeroallergens</td><td valign="top">SPT positive for at least 1 out of 12 common <break/>Aeroallergens</td></tr></tbody></table><table-wrap-foot><fn><p>FEV1: forced expiratory volume in one second, AHR: Airway Hyper Responsiveness, PC<sub>20</sub>: Provocative Concentration causing a 20% fall in FEV1, SPT: Skin Prick Test.</p></fn></table-wrap-foot></table-wrap>